Bioorganic and Medicinal Chemistry p. 2729 - 2740 (2019)
Update date:2022-08-29
Topics:
Ding, Huai-Wei
Wang, Shu
Qin, Xiao-Chun
Wang, Jian
Song, Hong-Rui
Zhao, Qing-Chun
Song, Shao-Jiang
A series of 4-aminoquinazolines derivatives containing hydrophilic group were designed and identified as potent Pan-PI3K inhibitors in this study. The results of antiproliferative assays in vitro showed that this series of compounds had strong inhibition of tumor growth, especially compound 7b for MCF-7 cells but weak inhibition to normal cells. PI3K kinase assay showed that 7b had high activity for three PI3K isoforms with the IC50 values of picomole. The western blot assay indicated that 7b could decrease the phospho-Akt (S473) in a dose-dependent manner. Further experiments showed that 7b could induce apoptosis in MCF-7 cells. Four key hydrogen bonding interactions were found in the docking of 7b with PI3K kinase. All these results suggested that 7b is a potent PI3K inhibitor and could be considered as a potential candidate for the development of anticancer agents.
View MoreContact:86-512-69362780,69362785
Address:No.69 Weixin Road,Weiting Town,Suzhou Industrial Park
Contact:86-574-26865651
Address:529 YuanBaoShan Road, Beilun District
Goldwills Pharmaceuticals Co., Ltd.
Contact:0916-2237889 13991621155
Address:North Suburb of Hanzhong city, Shaanxi Province
Shanghai SMEC Trading Co., Ltd.
website:http://www.shanghaismec.com
Contact:+86-21-68811293
Address:ROOM 1101,NO.800 SHANGCHENG RD,SHANGHAI,CHINA
Jewim Pharmaceutical (Shandong) Co., Ltd
Contact:+8615621883869
Address:山东省泰安市高新技术产业开发区配天门大街西首
Doi:10.1016/j.catcom.2018.11.017
(2019)Doi:10.1002/cbdv.201500356
(2016)Doi:10.1016/j.bmc.2005.09.013
(2006)Doi:10.1039/d0tb02801k
(2021)Doi:10.1021/ol034253j
(2003)Doi:10.1055/s-1975-23735
(1975)